Amgen (NASDAQ: AMGN) announced initiatives that will reduce company staff by 12-14 percent, citing lower Aranesp(R) revenues.

These initiatives ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE